These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 338271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deanol in minimal brain dysfunction.
    Lewis JA, Lewis BS.
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):21-4. PubMed ID: 590062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Walkup JT, Scahill LD, Riddle MA.
    Adv Neurol; 1995 Dec; 65():259-72. PubMed ID: 7872144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J.
    J Clin Psychiatry; 1998 Dec; 59 Suppl 7():4-16. PubMed ID: 9680048
    [Abstract] [Full Text] [Related]

  • 7. Minimal brain dysfunctions in children.
    Peters JE.
    Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR.
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract] [Full Text] [Related]

  • 14. Letter: Need for medication in minimal brain dysfunction.
    Levitis KA.
    Pediatrics; 1974 Sep; 54(3):388. PubMed ID: 4414312
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE.
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [Abstract] [Full Text] [Related]

  • 18. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR.
    Adv Pediatr; 1976 Aug; 23():113-49. PubMed ID: 795279
    [No Abstract] [Full Text] [Related]

  • 19. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
    Sangal JM, Sangal RB, Persky B.
    Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.